Clinical trial Recruiting at 6 sites Observational Ages 18 and up

Vliwazell Pro wound dressing follow-up for real-world use

Official title: Prospective Systematic Data Collection for Post-Marketing Surveillance of Vliwazell® Pro Wound Dressing

Run by Lohmann & Rauscher · NCT07316556 · Data updated 2026-11-12

This follow-up will see if Vliwazell Pro safely controls wound fluid and protects the skin around acute and chronic wounds in adults who need a high-absorbency dressing.

More Chronic Wounds trials

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment208 (estimated)
SponsorLohmann & Rauscher
Industry-sponsored
Locations8 sites (Aachen and 7 other locations)
StatusRecruiting
StartedMarch 11, 2024
Main results expectedJanuary 31, 2027
Study endsJanuary 31, 2027
Registry record updatedJanuary 5, 2026
Trial IDNCT07316556 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults (18+) with superficial acute or chronic wounds that produce moderate to very high amounts of exudate—such as venous, arterial, diabetic, pressure, post‑operative, oncologic wounds, or donor sites—who can give informed consent are ideal candidates.

Probably not a fit

Patients under 18, those with a known allergy to any dressing component, or patients with tunnel-forming wound pockets (a contraindication) are unlikely to benefit from participation.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This post-marketing, observational follow-up collects real-world data on the performance and safety of the Vliwazell Pro superabsorbent dressing during routine wound care. Clinicians will record wound characteristics such as exudate level, odor, and condition of the surrounding skin, along with any device-related adverse events. The study also gathers patient and healthcare provider satisfaction and documents dressing change frequency in everyday practice. No experimental interventions are assigned; the product is used according to its intended indications and standard care.

Why it matters

Potential benefit: If successful, the dressing could reduce the need for frequent changes, protect surrounding skin from maceration, and make wound care more convenient and comfortable for patients.

How similar studies have gone: Similar superabsorbent dressings have shown benefit in reducing maceration and dressing-change frequency in prior real-world and clinical reports, though product-specific post-market data for Vliwazell Pro are limited.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

Wound according to indication mentioned in the instructions for use:

1. Superficial acute and chronic wounds with moderate to very high amounts of exudate and that are superficial, in:

   * arterial and venous ulcers
   * diabetic ulcers
   * pressure ulcers
   * post-traumatic wounds
   * post-operative wounds healing by secondary intention
   * skin graft donor sites
   * oncological wounds
   * ulcerating tumors
   * wounds at risk of infection
   * superficial 2nd degree burns
   * lymphatic wounds
2. As secondary dressing on laparotomy wounds and fistulas or for deep wounds when used with appropriate wound filler
3. Patient has full legal capacity
4. Patient is able to understand and provide information
5. Patient has signed the written Informed Consent Form

Exclusion Criteria:

1. Age \< 18 years
2. Patient with contraindication:

   * Known allergy and/or hypersensitivity to any of the product components.
   * Not for use in tunnel-forming wound pockets, as the product may expand considerably with the absorption of wound exudate.
   * Not for use on dry wounds.
3. Pregnant or lactating women
4. Patients participating in another clinical trial at the time of inclusion
5. Patient not covered by health insurance/social security

Where it's running

  • Wundmanagement
    Aachen, Germany
    Recruiting
  • MVZ Hausärzte
    Brüggen, Germany
    Recruiting
  • ORGAMed
    Dortmund, Germany
    Recruiting
  • Hautklinik
    Erlangen, Germany
    Recruiting
  • Krankenhaus Tabea
    Hamburg, Germany
    Recruiting
  • Gesundheitsmanager, Inh. Christine Bertram
    Waidhaus, Germany
    Recruiting
Show 2 more locations
  • WKM Rösner Mönchengladbach
    Mönchengladbach, Germany
    Not yet recruiting
  • WKM Rösner Willich
    Willich, Germany
    Not yet recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Browse more
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.